Aprea Therapeutics, Inc. APRE Q1 2026 earnings

FAQ

When did Aprea Therapeutics, Inc. report Q1 2026 earnings?

Aprea Therapeutics, Inc. (APRE) reported Q1 2026 earnings on May 13, 2026 before market open.

What were Aprea Therapeutics, Inc.'s Q1 2026 revenue and EPS?

Aprea Therapeutics, Inc. reported revenue of $281.0K and eps of $-0.22 for Q1 2026.

Did Aprea Therapeutics, Inc. beat estimates in Q1 2026?

EPS beat the consensus estimate of $-0.23 by $0.01.

How did Aprea Therapeutics, Inc.'s Q1 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 73.0% from $162.5K a year earlier and eps grew 66.7% from $-0.66.

Where can I find Aprea Therapeutics, Inc.'s Q1 2026 SEC filings?

You can read the 8-K earnings release (0001104659-26-059734) and the 10-Q periodic report (0001104659-26-059743) directly on SEC EDGAR. The filing index links above go to sec.gov.